{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:23:27Z","timestamp":1793255007556,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00223-013-9778-7","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T06:43:23Z","timestamp":1377845003000},"page":"436-447","source":"Crossref","is-referenced-by-count":30,"title":["18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease"],"prefix":"10.1007","volume":"93","author":[{"given":"Michelle L.","family":"Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet E.","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen M.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musib","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Skingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignac","family":"Fogelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"issue":"9811","key":"9778_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165\u2013180","journal-title":"Lancet"},{"key":"9778_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12018-011-9119-1","volume":"10","author":"K Kiattisunthorn","year":"2012","unstructured":"Kiattisunthorn K, Moe SM (2012) Chronic kidney disease-mineral bone disorder: definitions and rationale for a systemic disorder. Clin Rev Bone Miner Metab 10:119\u2013127","journal-title":"Clin Rev Bone Miner Metab"},{"key":"9778_CR3","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368\u20131376 Erratum in J Bone Miner Res 2011;26:2793","journal-title":"J Bone Miner Res"},{"key":"9778_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, Osteoporotic Fractures Research Group (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133\u2013139","journal-title":"Arch Intern Med"},{"key":"9778_CR5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1755.2003.00837.x","volume":"63","author":"MW Taal","year":"2003","unstructured":"Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116\u20131120","journal-title":"Kidney Int"},{"key":"9778_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ndtplus\/sfn040","volume":"3","author":"VM Brandenburg","year":"2008","unstructured":"Brandenburg VM, Floege J (2008) Adynamic bone disease\u2014bone and beyond. NDT Plus 3:135\u2013147","journal-title":"NDT Plus"},{"issue":"Suppl 2","key":"9778_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2362.2006.01666.x","volume":"36","author":"C Schwarz","year":"2006","unstructured":"Schwarz C, Sulzbacher I, Oberbauer R (2006) Diagnosis of renal osteodystrophy. Eur J Clin Invest 36(Suppl 2):13\u201322","journal-title":"Eur J Clin Invest"},{"key":"9778_CR8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","volume":"46","author":"P Kurz","year":"1994","unstructured":"Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855\u2013861","journal-title":"Kidney Int"},{"key":"9778_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10157-011-0577-z","volume":"16","author":"H Rhee","year":"2012","unstructured":"Rhee H, Song SH, Kwak IS, Lee SB, Lee DW, Seong EY, Kim IY (2012) Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients. Clin Exp Nephrol 16:433\u2013441","journal-title":"Clin Exp Nephrol"},{"key":"9778_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","volume":"47","author":"MD Danese","year":"2006","unstructured":"Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47:149\u2013156","journal-title":"Am J Kidney Dis"},{"key":"9778_CR11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/j.ajkd.2009.02.010","volume":"53","author":"D Goldsmith","year":"2009","unstructured":"Goldsmith D, Kothawala P, Chalian A, Bernal M, Robbins S, Covic A (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis 53:1002\u20131013","journal-title":"Am J Kidney Dis"},{"key":"9778_CR12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","volume":"38","author":"MM Avram","year":"2001","unstructured":"Avram MM, Mittman N, Myint MM, Fein P (2001) Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14\u00a0years of prospective observation. Am J Kidney Dis 38:1351\u20131357","journal-title":"Am J Kidney Dis"},{"key":"9778_CR13","doi-asserted-by":"crossref","first-page":"c211","DOI":"10.1159\/000321642","volume":"118","author":"G Jean","year":"2011","unstructured":"Jean G, Lataillade D, Genet L, Legrand E, Kuentz F, Moreau-Gaudry X, Fouque D, ARNOS Study Investigators (2011) Association between very low PTH levels and poor survival rates in hemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract 118:c211\u2013c216","journal-title":"Nephron Clin Pract"},{"key":"9778_CR14","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013S130","journal-title":"Kidney Int Suppl"},{"key":"9778_CR15","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2215\/CJN.02430508","volume":"3","author":"PD Miller","year":"2008","unstructured":"Miller PD (2008) The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol 3:S140\u2013S150","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"9778_CR16","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","volume":"3","author":"SM Ott","year":"2008","unstructured":"Ott SM (2008) Histomorphometric measurements of bone turnover, mineralization, and volume. Clin J Am Soc Nephrol 3(Suppl 3):S151\u2013S156","journal-title":"Clin J Am Soc Nephrol"},{"key":"9778_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res"},{"key":"9778_CR18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bone.2011.07.017","volume":"49","author":"RR Recker","year":"2011","unstructured":"Recker RR, Kimmel DB, Dempster D, Weinstein RS, Wronski TJ, Burr DB (2011) Issues in modern bone histomorphometry. Bone 49:955\u2013964","journal-title":"Bone"},{"key":"9778_CR19","first-page":"S22","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S22\u2013S49","journal-title":"Kidney Int Suppl"},{"key":"9778_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","volume":"8","author":"G Garrett","year":"2013","unstructured":"Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJ (2013) PTH\u2014a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol 8:299\u2013312","journal-title":"Clin J Am Soc Nephrol"},{"key":"9778_CR21","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","volume":"13","author":"G Coen","year":"1998","unstructured":"Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F (1998) Bone markers in the diagnosis of low turnover osteodystrophy in hemodialysis patients. Nephrol Dial Transplant 13:2294\u20132302","journal-title":"Nephrol Dial Transplant"},{"key":"9778_CR22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5414\/CNP70296","volume":"70","author":"G Lehmann","year":"2008","unstructured":"Lehmann G, Ott U, Kaemmerer D, Schuetze J, Wolf G (2008) Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3\u20135. Clin Nephrol 70:296\u2013305","journal-title":"Clin Nephrol"},{"key":"9778_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12018-011-9122-6","volume":"10","author":"LA Negrea","year":"2012","unstructured":"Negrea LA (2012) Biochemical abnormalities in chronic kidney disease-mineral bone disease. Clin Rev Bone Miner Metab 10:149\u2013162","journal-title":"Clin Rev Bone Miner Metab"},{"key":"9778_CR24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Ure\u00f1a","year":"1999","unstructured":"Ure\u00f1a P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodelling in uremic patients. Kidney Int 55:2141\u20132156","journal-title":"Kidney Int"},{"key":"9778_CR25","first-page":"633","volume":"33","author":"RA Hawkins","year":"1992","unstructured":"Hawkins RA, Choi Y, Huang S-C, Hoh CK, Dahlbom M, Schiepers C, Satyamurthy N, Barrio JR, Phelps ME (1992) Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 33:633\u2013642","journal-title":"J Nucl Med"},{"key":"9778_CR26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1210\/jc.77.4.949","volume":"77","author":"C Messa","year":"1993","unstructured":"Messa C, Goodman WG, Hoh CK, Choi Y, Nissenson AR, Salusky IB, Phelps ME, Hawkins RA (1993) Bone metabolic activity measured with positron emission tomography and 18F-fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab 77:949\u2013955","journal-title":"J Clin Endocrinol Metab"},{"key":"9778_CR27","first-page":"1091","volume":"42","author":"M Piert","year":"2001","unstructured":"Piert M, Zittel TT, Becker GA, Jahn M, Stahlschmidt A, Maier G, Machulla HJ, Bares R (2001) Assessment of porcine bone metabolism by dynamic 18F-fluoride PET: correlation with bone histomorphometry. J Nucl Med 42:1091\u20131100","journal-title":"J Nucl Med"},{"key":"9778_CR28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1359\/jbmr.2002.17.5.854","volume":"17","author":"GJR Cook","year":"2002","unstructured":"Cook GJR, Blake GM, Marsden PK, Cronin B, Fogelman I (2002) Quantification of skeletal kinetic indices in Paget\u2019s disease using dynamic 18F-fluoride positron emission tomography. J Bone Miner Res 17:854\u2013859","journal-title":"J Bone Miner Res"},{"key":"9778_CR29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1359\/JBMR.040818","volume":"19","author":"ML Frost","year":"2004","unstructured":"Frost ML, Fogelman I, Blake GM, Marsden PK, Fogelman I (2004) Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. J Bone Miner Res 19:1797\u20131804","journal-title":"J Bone Miner Res"},{"key":"9778_CR30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bone.2009.07.081","volume":"45","author":"ML Frost","year":"2009","unstructured":"Frost ML, Blake GM, Cook GJ, Marsden PK, Fogelman I (2009) Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: 18F-fluoride PET study of treatment-naive and treated postmenopausal women. Bone 45:942\u2013948","journal-title":"Bone"},{"key":"9778_CR31","first-page":"1650","volume":"46","author":"J Installe","year":"2005","unstructured":"Installe J, Nzeusseu A, Bol A, Depresseux G, Devogelaer JP, Lonneux M (2005) 18F-fluoride PET for monitoring therapeutic response in Paget\u2019s disease of bone. J Nucl Med 46:1650\u20131658","journal-title":"J Nucl Med"},{"key":"9778_CR32","first-page":"117","volume":"44","author":"M Piert","year":"2003","unstructured":"Piert M, Zittel TT, Jahn M, Stahlschmidt A, Becker GA, Machulla H-J (2003) Increased sensitivity in detection of a porcine high-turnover osteopenia after total gastrectomy by dynamic 18F-fluoride ion PET and quantitative CT. J Nucl Med 44:117\u2013124","journal-title":"J Nucl Med"},{"key":"9778_CR33","first-page":"1970","volume":"38","author":"C Schiepers","year":"1997","unstructured":"Schiepers C, Nuyts J, Bormans G, Dequeker J, Bouillon R, Mortelmans L, Verbruggen A, De Roo M (1997) Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med 38:1970\u20131976","journal-title":"J Nucl Med"},{"key":"9778_CR34","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1359\/jbmr.2003.18.12.2215","volume":"18","author":"ML Frost","year":"2003","unstructured":"Frost ML, Cook GJ, Blake GM, Marsden PK, Benatar NA, Fogelman I (2003) A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. J Bone Miner Res 18:2215\u20132222","journal-title":"J Bone Miner Res"},{"key":"9778_CR35","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jbmr.305","volume":"26","author":"ML Frost","year":"2011","unstructured":"Frost ML, Siddique M, Blake GM, Moore AE, Schleyer PJ, Dunn JT, Somer EJ, Marsden PK, Eastell R, Fogelman I (2011) Differential effects of teriparatide on regional bone formation using 18F-fluoride positron emission tomography. J Bone Miner Res 26:1002\u20131011","journal-title":"J Bone Miner Res"},{"key":"9778_CR36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2967\/jnumed.109.062570","volume":"50","author":"K Uchida","year":"2009","unstructured":"Uchida K, Nakajima H, Miyazaki T, Yayama T, Kawahara H, Kobayashi S, Tsuchida T, Okazawa H, Fujibayashi Y, Baba H (2009) Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study. J Nucl Med 50:1808\u20131814","journal-title":"J Nucl Med"},{"key":"9778_CR37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jbmr.1862","volume":"28","author":"ML Frost","year":"2013","unstructured":"Frost ML, Moore AE, Siddique M, Blake GM, Laurent D, Borah B, Schramm U, Valentin M-A, Pellas TC, Marsden PK, Schleyer PJ, Fogelman I (2013) 18F-fluoride PET as a non-invasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study. J Bone Miner Res 28:1337\u20131347","journal-title":"J Bone Miner Res"},{"key":"9778_CR38","volume-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical support series 843","author":"World Health Organisation","year":"1994","unstructured":"World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical support series 843. WHO, Geneva"},{"key":"9778_CR39","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2967\/jnumed.111.093195","volume":"52","author":"M Siddique","year":"2011","unstructured":"Siddique M, Frost ML, Blake GM, Moore AE, Al-Beyatti Y, Marsden PK, Schleyer PJ, Fogelman I (2011) The precision and sensitivity of 18F-fluoride PET for measuring regional bone metabolism: a comparison of quantification methods. J Nucl Med 52:1748\u20131755","journal-title":"J Nucl Med"},{"key":"9778_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00259-011-1966-y","volume":"39","author":"M Siddique","year":"2012","unstructured":"Siddique M, Blake GM, Frost ML, Moore AE, Puri T, Marsden PK, Fogelman I (2012) Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images. Eur J Nucl Med Mol Imaging 39:337\u2013343","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9778_CR41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/MNM.0b013e3283550275","volume":"33","author":"GM Blake","year":"2012","unstructured":"Blake GM, Siddique M, Puri T, Frost ML, Moore AE, Cook GJ, Fogelman I (2012) A semipopulation input function for quantifying static and dynamic 18F-fluoride PET scans. Nucl Med Commun 33:881\u2013888","journal-title":"Nucl Med Commun"},{"issue":"Suppl 5","key":"9778_CR42","first-page":"S577","volume":"23","author":"M Siddique","year":"2012","unstructured":"Siddique M, Frost ML, Moore AE, Fogelman I, Blake GM (2012) Whole body 18F-fluoride PET measurements of regional bone formation. Osteoporos Int 23(Suppl 5):S577","journal-title":"Osteoporos Int"},{"key":"9778_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"DR Carter","year":"1992","unstructured":"Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137\u2013145","journal-title":"J Bone Miner Res"},{"key":"9778_CR44","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfq513","volume":"25","author":"DJ Goldsmith","year":"2010","unstructured":"Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R (2010) Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant 25:3823\u20133831","journal-title":"Nephrol Dial Transplant"},{"key":"9778_CR45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moys\u00e9s RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u2013777","journal-title":"Kidney Int"},{"key":"9778_CR46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/ajkd.2000.19093","volume":"36","author":"M Carmen S\u00e1nchez","year":"2000","unstructured":"Carmen S\u00e1nchez M, Auxiliadora Bajo M, Selgas R, Mate A, Mill\u00e1n I, Eugenia Mart\u00ednez M, L\u00f3pez-Barea F (2000) Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. Am J Kidney Dis 36:953\u2013961","journal-title":"Am J Kidney Dis"},{"key":"9778_CR47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","volume":"47","author":"A Torres","year":"1995","unstructured":"Torres A, Lorenzo V, Hern\u00e1ndez D, Rodr\u00edguez JC, Concepci\u00f3n MT, Rodr\u00edguez AP, Hern\u00e1ndez A, de Bonis E, Darias E, Gonz\u00e1lez-Posada JM et al (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47:1434\u20131442","journal-title":"Kidney Int"},{"issue":"5","key":"9778_CR48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","volume":"26","author":"M Wang","year":"1995","unstructured":"Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y (1995) Relationship between intact 1\u201384 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26(5):836\u2013844","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"9778_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1744-9987.12038","volume":"17","author":"A Yajima","year":"2013","unstructured":"Yajima A, Inaba M, Tominaga Y, Tanaka M, Otsubo S, Nitta K, Ito A, Satoh S (2013) Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease. Ther Apher Dial 17(Suppl 1):41\u201348","journal-title":"Ther Apher Dial"},{"key":"9778_CR50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","volume":"12","author":"AM Parfitt","year":"2003","unstructured":"Parfitt AM (2003) Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 12:387\u2013403","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9778_CR51","first-page":"117","volume":"18","author":"G Coen","year":"2005","unstructured":"Coen G (2005) Adynamic bone disease: an update and overview. J Nephrol 18:117\u2013122","journal-title":"J Nephrol"},{"issue":"Suppl 3","key":"9778_CR52","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2215\/CJN.02500607","volume":"3","author":"HH Malluche","year":"2008","unstructured":"Malluche HH, Mawad H, Monier-Faugere MC (2008) Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol 3(Suppl 3):S157\u2013S163","journal-title":"Clin J Am Soc Nephrol"},{"key":"9778_CR53","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","volume":"12","author":"IB Salusky","year":"2001","unstructured":"Salusky IB, Goodman WG (2001) Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol 12:1978\u20131985","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"9778_CR54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","volume":"29","author":"R Amerling","year":"2010","unstructured":"Amerling R, Harbord NB, Pullman J, Feinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29(3):293\u2013299","journal-title":"Blood Purif"},{"key":"9778_CR55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garc\u00eda-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23:6\u201316","journal-title":"J Bone Miner Res"},{"issue":"8","key":"9778_CR56","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1210\/jc.2012-1262","volume":"97","author":"DW Dempster","year":"2012","unstructured":"Dempster DW, Zhou H, Recker RR, Brown JP, Bolognese MA, Recknor CP, Kendler DL, Lewiecki EM, Hanley DA, Rao DS, Miller PD, Woodson GC 3rd, Lindsay R, Binkley N, Wan X, Ruff VA, Janos B, Taylor KA (2012) Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial. J Clin Endocrinol Metab 97(8):2799\u20132808","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9778_CR57","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","volume":"25","author":"IR Reid","year":"2010","unstructured":"Reid IR, Miller PD, Brown JP, Kendler DL, Fahrleitner-Pammer A, Valter I, Maasalu K, Bolognese MA, Woodson G, Bone H, Ding B, Wagman RB, San Martin J, Ominsky MS, Dempster DW, Denosumab Phase 3 Bone Histology Study Group (2010) Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res 25(10):2256\u20132265","journal-title":"J Bone Miner Res"},{"issue":"3","key":"9778_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1359\/jbmr.080703","volume":"24","author":"SJ Glover","year":"2009","unstructured":"Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Black DM, Delmas PD, Eastell R (2009) Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 24(3):389\u2013397","journal-title":"J Bone Miner Res"},{"issue":"3","key":"9778_CR59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00774-007-0826-0","volume":"26","author":"Y Nishizawa","year":"2008","unstructured":"Nishizawa Y, Inaba M, Ishii M, Yamashita H, Miki T, Goto H, Yamada S, Chaki O, Kurasawa K, Mochizuki Y (2008) Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects. J Bone Miner Metab 26(3):265\u2013270","journal-title":"J Bone Miner Metab"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-013-9778-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9778-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:06:43Z","timestamp":1646453203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-013-9778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["9778"],"URL":"https:\/\/doi.org\/10.1007\/s00223-013-9778-7","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}